Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Elite Pharmaceuticals Inc. (ELTP) had Debt to Capital Ratio of 0.07 for the most recently reported fiscal year, ending 2025-03-31.
| Income Statement Financials | |
$84.04M |
|
$-4.31M |
|
$43.96M |
|
$40.09M |
|
$64.44M |
|
$19.60M |
|
$-19.65M |
|
$-0.05M |
|
$-0.05M |
|
$-4.31M |
|
$-4.31M |
|
$-4.31M |
|
$-4.31M |
|
$19.60M |
|
$21.74M |
|
1.07B |
|
1.07B |
|
$0.00 |
|
$0.00 |
|
| Balance Sheet Financials | |
$57.74M |
|
$10.33M |
|
$38.65M |
|
$96.39M |
|
$11.84M |
|
$4.28M |
|
$31.03M |
|
$42.87M |
|
$53.52M |
|
$47.88M |
|
$53.52M |
|
1.07B |
|
| Cash Flow Statement Financials | |
$7.46M |
|
$-2.40M |
|
$-0.83M |
|
$7.54M |
|
$11.77M |
|
$4.23M |
|
$0.23M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.88 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.07 |
0.17 |
|
47.70% |
|
23.32% |
|
23.32% |
|
25.86% |
|
-0.06% |
|
-5.13% |
|
$5.96M |
|
-- |
|
-- |
|
-- |
|
0.87 |
|
2.71 |
|
2.88 |
|
126.85 |
|
-8.06% |
|
-9.01% |
|
-4.48% |
|
-7.47% |
|
$0.05 |
|
$0.01 |
|
$0.01 |
|